+1-800-267-5763
Category Archives: For Ophthalmologists
Organ Culture of Corneas and its Role in Eye Banking Economics
Nov 10th, 2022
Date: Wednesday, November 30, 2022 Time: 4:00-5:30pm ET. Presented by Dr. Graeme Pollock, Director of Lions Eye Donation Service, Centre for Eye Research AustraliaHosted by Gary Rockl, Tissue Innovation Specialist from Héma-Québec The presentation will examine the technical aspects of organ culture of donor corneas and the benefits that may accrue through its adoption. It […]
COS EDI Webinar – LGBTQ2S+ Issues in Ophthalmology: Working Towards Equity
Nov 4th, 2022
COS EDI Webinar: November 23, 8PM ET LGBTQ2S+ Issues in Ophthalmology: Working Towards Equity Join us on Wednesday, November 23 as COS presents a webinar entitled LGBTQ2S+ Issues in Ophthalmology: Working Towards Equity, presented by Dr. Michael A. Puente. In this 1.5-hour webinar, we will examine the status of health equity for LGBTQ2S+ patients and […]
CMA Health Summit Series
Oct 20th, 2022
Date: Wednesday, October 26th, 2022 Time: 5:30 – 7:30 pm, EST Location: Online There is an urgent need to stabilize the health care system – as well as growing calls for its transformation. Solutions are not in short supply. But getting from now to next depends on bold choices. The CMA is hosting a series of […]
ESCRS Launches Online IOL Calculator
Oct 20th, 2022
The developers’ goal was to create a free online tool that helps ophthalmologists aggregate the major online IOL calculators in one site, allowing them to get multiple results with only one data entry session. “This will reduce typing mistakes, provide a better view, and allow users to compare results, eventually helping to get better refractive […]
The 14th Annual Congress on Controversies in Ophthalmology
Oct 20th, 2022
The 14th Annual Congress on Controversies in Ophthalmology: (COPHy) taking place in Lisbon, Portugal, March 24-25, 2023. Date: March 24- 25, 2023 Location: Lisbon, Portugal The great success of the previous COPHy Congresses, held across Europe in Prague, Barcelona, Istanbul, Budapest, Lisbon, Sorrento, Warsaw, Madrid, Athens and Dublin as well as the enthusiastic feedback received […]
Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis.
Oct 20th, 2022
We are pleased to share with you the Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis. These Canadian JIA-associated uveitis guidelines were developed by a working group of 14 pediatric rheumatologists, 6 ophthalmologists, 2 methodologists and 3 caregiver/patient representatives using a GRADE-Adolopment approach applied to the 2019 ACR JIA-Associated […]
61st Annual Ophthalmology Update Walter Wright Symposium
Oct 18th, 2022
Title: Walter Wright 20/20+2: Cornea, Anterior Segment and Refractive Surgery Date: December 2nd – 3rd Location: Metro Toronto Convention Centre, Toronto, ON Guest Speakers: Drs. Anthony J. Aldave, James Chodosh, Sadeer B. Hannush, Carol L. Karp, Terry Kim, Christopher J. Rapuano, Elmer Tu, Stephanie Watson This year’s Walter Wright program will showcase an exciting and relevant presentation […]
CJO: October 2022 Issue Highlights
Oct 18th, 2022
The October 2022 CJO is now available online. Here are some of the highlights: Resident Perspectives + visual abstract: Our amazing team of residents have summarized 6 articles with a focus on what’s most relevant to ophthalmology learners here in Canada and around the globe, including the article featured in our October visual abstract, Macular […]
Canadian Ophthalmological Society (COS) Joint Position Statement on Biosimilar Drugs
Oct 17th, 2022
October 2022 Canadian Ophthalmological Society (COS) Joint Position Statement on Biosimilar Drugs Biosimilar biologic drugs (biosimilars*) were introduced in the Canadian market in 2009. The first ophthalmic biosimilar for intravitreal injection is expected to be launched in Canada in the late fall of 2022. With this launch, it is expected that use of biosimilars across […]